Skip to main content

Table 3 Life-time neurodevelopmental/psychiatric disorders in females with TS stratified by year of Turner diagnosis and compared with age-matched controls (1:100 controls)

From: Neurodevelopmental and psychiatric disorders in females with Turner syndrome: a population-based study

Diagnoses

< 1987

1987–2001

> 2001

Turner syndrome, N (%)

Matched controls, N (%)

OR (95%CI)

P value

Turner syndrome, N (%)

Matched controls, N (%)

OR (95%CI)

P value

Turner syndrome, N (%)

Matched controls, N (%)

OR (95%CI)

P value

Any NDDs psychiatric disorders

81 (24.70)

5641 (17.20)

1.59 (1.23–2.04)

0.0006

94 (19.75)

8550 (17.96)

1.12 (0.90–1.41)

0.3168

108 (18.37)

7757 (13.19)

1.51 (1.21–1.87)

0.0003

Mental and behavioral disorders due to psychoactive substance use

9 (2.74)

1177 (3.59)

0.76 (0.39–1.47)

0.3927

9 (1.89)

1983 (4.17)

0.44 (0.23–0.86)

0.0056

12 (2.04)

1475 (2.51)

0.81 (0.45–1.44)

0.4529

Schizophrenia and related disorders

15 (4.57)

595 (1.81)

2.61 (1.54–4.42)

0.0017

7 (1.47)

497 (1.04)

1.42 (0.67–3.03)

0.3886

7 (1.19)

401 (0.68)

1.77 (0.83–3.77)

0.1759

Mood disorders (including bipolar, single, and recurrent depressive disorder)

25 (7.62)

2382 (7.26)

1.05 (0.70–1.59)

0.8039

22 (4.62)

3480 (7.31)

0.61 (0.40–0.94)

0.0164

32 (5.44)

2744 (4.67)

1.18 (0.82–1.70)

0.3808

Suicide attempt

5 (1.52)

440 (1.34)

1.14 (0.47–2.78)

0.7786

8 (1.68)

981 (2.06)

0.81 (0.40–1.64)

0.5473

6 (1.02)

737 (1.25)

0.81 (0.36–1.82)

0.5999

Anxiety disorders (including dissociative, stress-related, and somatoform disorders)

34 (10.37)

2915 (8.89)

1.19 (0.83–1.70)

0.3587

28 (5.88)

4555 (9.57)

0.59 (0.40–0.86)

0.0035

34 (5.78)

3740 (6.36)

0.90 (0.63–1.28)

0.556

Eating disorders

4 (1.22)

207 (0.63)

1.95 (0.72–5.32)

0.2344

19 (3.99)

793 (1.67)

2.48 (1.55–3.97)

0.0008

9 (1.53)

609 (1.04)

1.49 (0.77–2.92)

0.2679

Disorders of adult personality and behavior

6 (1.83)

509 (1.55)

1.18 (0.52–2.67)

0.6938

5 (1.05)

745 (1.57)

0.67 (0.28–1.62)

0.3376

6 (1.02)

466 (0.79)

1.29 (0.57–2.92)

0.5514

Mental retardation (ID)

14 (4.27)

123 (0.38)

12.0 (6.78–21.07)

< .0001

20 (4.20)

287 (0.60)

7.29 (4.58–11.59)

< .0001

28 (4.76)

350 (0.60)

8.45 (5.69–12.57)

< .0001

Pervasive developmental disorders (ASD)

7 (2.13)

84 (0.26)

8.56 (3.92–18.71)

< .0001

11 (2.31)

303 (0.64)

3.74 (2.02–6.91)

0.0004

12 (2.04)

339 (0.58)

3.63 (2.02–6.52)

0.0003

Hyperkinetic disorders (ADHD)

0 (0.00)

205 (0.63)

0.00 (0.00-)

0.0428

9 (1.89)

709 (1.49)

1.28 (0.66–2.49)

0.4882

13 (2.21)

818 (1.39)

1.62 (0.92–2.83)

0.1173

Behavioral and emotional disorders with onset in childhood

2 (0.61)

92 (0.28)

2.19 (0.53–8.99)

0.3316

6 (1.26)

424 (0.89)

1.43 (0.63–3.22)

0.4195

18 (3.06)

803 (1.37)

2.31 (1.43–3.74)

0.0023

  1. OR odds ratio, NDD neurodevelopmental disorder, ID intellectual disability, ASD autism spectrum disorder, ADHD attention deficit hyperactivity disorder
  2. *Due to difference in the observation time, percentage of life-time psychiatric outcome may not be comparable between cohorts